ZYBT

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.15
Percentage change -2.56	%

Held by: PGJ

Scroll to Statements

Index	-	P/E	171.77	EPS (ttm)	0.03	Insider Own	90.66%	Shs Outstand	47.17M	Perf Week	-5.14%
Market Cap	271.07M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.43M	Perf Month	-21.54%
Enterprise Value	289.56M	PEG	-	EPS next Q	-	Inst Own	0.00%	Short Float	5.90%	Perf Quarter	40.89%
Income	1.57M	P/S	10.47	EPS this Y	-	Inst Trans	15.03%	Short Ratio	0.49	Perf Half Y	23.91%
Sales	25.89M	P/B	6.94	EPS next Y	-	ROA	2.27%	Short Interest	0.26M	Perf YTD	17.70%
Book/sh	0.82	P/C	98.57	EPS next 5Y	-	ROE	4.06%	52W High	14.30 -60.00%	Perf Year	-
Cash/sh	0.06	P/FCF	70.78	EPS past 3/5Y	-36.18% -	ROIC	3.97%	52W Low	3.50 63.43%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	51.71	Sales past 3/5Y	-7.94% -	Gross Margin	48.96%	Volatility	11.06% 16.17%	Perf 5Y	-
Dividend TTM	-	EV/Sales	11.18	EPS Y/Y TTM	-64.87%	Oper. Margin	8.80%	ATR (14)	1.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.80	Sales Y/Y TTM	-13.57%	Profit Margin	6.06%	RSI (14)	43.09	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.31	EPS Q/Q	-79.39%	SMA20	-14.98%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.30	Sales Q/Q	-2.78%	SMA50	-27.81%	Rel Volume	0.11	Prev Close	5.87
Employees	277	LT Debt/Eq	0.02	Earnings	-	SMA200	-9.68%	Avg Volume	533.16K	Price	5.72
IPO	Jan 07, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	11,509	Change	-2.56%

Jul-03-25 08:30AM	Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results (PR Newswire)
May-23-25 04:05PM	Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F (GlobeNewswire) -12.33%
Jan-14-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option (GlobeNewswire)
Jan-08-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering (GlobeNewswire) -7.41%
Jan-06-25 05:50PM	Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Zhengye Biotechnology Holding Ltd

Upgrade your FINVIZ experience